1 The ductus venosus is actively regulated in the fetus, but questions remain on the presence of a functional sphincter at its inlet. Using fetal sheep (0.6-0.7 gestation onwards), we have examined the morphology of the vessel and have also determined whether endothelin-1 (ET-1) qualifies as a natural constrictor being modulated by prostaglandins (PGs). 2 Masson's staining and a-actin immunohistochemistry showed a muscular, sphincter-like formation at the ductus inlet and a muscle layer within the wall of the vessel proper. This muscle cell component increased with age. 3 ET-1 contracted dose-dependently isolated sphincter and extrasphincter preparations of the ductus from term fetus. This ET-1 effect also occurred in the premature, but its threshold was higher. 4 BQ123 (1 mM) caused a rightward shift in the ET-1 dose-response curve, while indomethacin at a threshold concentration (28 nM) tended to have an opposite effect. 5 Big ET-1 also contracted the ductus sphincter but differed from ET-1 for its lesser potency and inhibition by phosphoramidon (50 mM). 6 The ductus sphincter (term and preterm) and extrasphincter (term) released 6-keto-PGF 1a (hence PGI 2 ) and, to a lesser degree, PGE 2 at rest and their release increased dose-dependently upon ET-1 treatment. Both basal and stimulated release was curtailed by endothelium removal. 7 BQ123 and phosphoramidon reduced slightly the contraction of ductus sphincter to indomethacin (2.8 mM). 8 We conclude that the ductus contains a contractile mechanism in the sphincter and extrasphincter regions. ET-1 lends itself to a role in the generation of contractile tone and its action may be modulated by prostaglandins.